United Kingdom Market: Proton Therapy
United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients
Treated at Proton Facility & Forecast. UK Proton Therapy Market is expected
to grow with a CAGR of 82% in future. United Kingdom Proton Therapy Market is
expected to grow 10 times from its current market in 2016. Currently UK has
only one Proton Therapy facility, at Clatterbridge cancer center and it’s a
‘low-energy’ machine, only suitable for treating people with rare eye cancers.
Treating more complex cancers requires a ‘high-energy’ beam, so the NHS covers
the cost of sending patients for treatment overseas (in the US or Switzerland)
when there’s clear evidence that proton beam therapy is the best option.
However this scenario is expected to make a drastic change in the next few
years as United Kingdom will have at least 6 Proton Therapy Centers.
The report provides a comprehensive assessment of the fast-evolving,
high-growth of Proton Therapy Market. In this report we have studied the market
in two parts a) Actual Market and b) Untapped Market. The report also talks
about list of all Operational and about to be opened Proton Therapy Facility;
Proton Therapy Reimbursement Policies in United Kingdom. Proton Therapy
revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been
studied in the report.
a) Actual Market is the current market which is already present
b) Untapped Market is the market which can be achieved; but it has yet
not been achieved due to demand and supply gap. At present only a few proton
therapy centers are available that can treat a limited number of patients each
year.
United
Kingdom Proton Therapy Market has been analyzed from four view points
• UK Proton Therapy Actual Market & Forecast (2009 – 2021)
• UK Proton Therapy Untapped Market & Forecast (2009 – 2021)
• UK Proton Therapy Treated Patient Numbers & Forecast (2009 – 2021)
• UK Proton Therapy Untapped Patient Numbers & Forecast (2009 – 2021)
Key
Companies Covered
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)
To view
Full Report: United
Kingdom Proton Therapy Market
Key
Questions Answered in the Report?
• What is the Proton Therapy Market in United Kingdom & its growth
potential in Future?
• What is the untapped market in United Kingdom Proton Therapy and its
Future?
• How many Proton Therapy Facilities are operating in United Kingdom?
• How many Proton Therapy Facilities are going to open in near Future?
• What is the number of people being treated in these Proton Therapy
Centers yearly?
• Is Proton Therapy Treatment being covered in the Reimbursement policy
of United Kingdom?
• What are the sales of Proton Therapy Companies Globally (IBA, Varian,
Elekta)?
India Pharma has started expanding in other regulated markets (Japan,
Germany, France, Canada) and Tier-II countries (Brazil, Mexico, Venezuela,
Russia, etc.). To explore further opportunities of growth, Indian Pharma
companies have started developing complex generics/ biosimilars. Almost all
companies, among Top-20 list, have robust pipeline in this value chain,
targeting primarily emerging markets; however, they are also capitalizing on
their competitiveness and capabilities to enter into the regulated market.
More Related Reports @ India
Pharma Outlook 2016
About Aarkstore
Aarkstore Enterprise
is a leading provider of business and financial information and solutions
worldwide. We specialize in providing online market business information on
market research reports, books, magazines, conference at competitive prices, and
strive to provide excellent and innovative service to our customers.
Contact
Details:
Aarkstore
Phone: 91 - 998 729 5242
Comments
Post a Comment